These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10079883)

  • 1. [Neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Lille experience 1980-1996].
    Cartigny-Maciejewski M; Guilley N; Vanderbecken S; Gondé S; Stuckens C; Ponté C; Weill J; Farriaux JP; Paux E
    Arch Pediatr; 1999 Feb; 6(2):151-8. PubMed ID: 10079883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.
    Thil'en A; Nordenström A; Hagenfeldt L; von Döbeln U; Guthenberg C; Larsson A
    Pediatrics; 1998 Apr; 101(4):E11. PubMed ID: 9521977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
    Hayashi GY; Carvalho DF; de Miranda MC; Faure C; Vallejos C; Brito VN; Rodrigues AS; Madureira G; Mendonca BB; Bachega TA
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation.
    Kopacek C; Prado MJ; da Silva CMD; de Castro SM; Beltrão LA; Vargas PR; Grandi T; Rossetti MLR; Spritzer PM
    J Pediatr (Rio J); 2019; 95(3):282-290. PubMed ID: 29715434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
    BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing.
    Gong LF; Gao X; Yang N; Zhao JQ; Yang HH; Kong YY
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):253-258. PubMed ID: 30817302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.
    Jiang X; Tang F; Feng Y; Li B; Jia X; Tang C; Liu S; Huang Y
    J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1253-1258. PubMed ID: 31603856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
    al Saedi S; Dean H; Dent W; Stockl E; Cronin C
    Pediatrics; 1996 Jan; 97(1):100-2. PubMed ID: 8545200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
    Votava F; Török D; Kovács J; Möslinger D; Baumgartner-Parzer SM; Sólyom J; Pribilincová Z; Battelino T; Lebl J; Frisch H; Waldhauser F;
    Eur J Endocrinol; 2005 Jun; 152(6):869-74. PubMed ID: 15941926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
    Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of 17 OH progesterone in blood in Chilean newborns: antecedents for implementing a grogram for the neonatal detection of congenital adrenal hyperplasia].
    Cattani A; Reyes ML; Azócar M; Soto J; Romeo E; Valdivia L; Poggi H; Foradori A
    Rev Med Chil; 2000 Oct; 128(10):1113-8. PubMed ID: 11349510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
    Cavarzere P; Camilot M; Teofoli F; Tatò L
    Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
    Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
    J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
    Balsamo A; Cacciari E; Piazzi S; Cassio A; Bozza D; Pirazzoli P; Zappulla F
    Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
    Varness TS; Allen DB; Hoffman GL
    J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
    Nordenström A; Wedell A; Hagenfeldt L; Marcus C; Larsson A
    Pediatrics; 2001 Oct; 108(4):E68. PubMed ID: 11581476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal screening for congenital adrenal hyperplasia.
    van der Kamp HJ; Wit JM
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U71-5. PubMed ID: 15554889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal screening for congenital adrenal hyperplasia: experience and results in Argentina.
    Gruñieiro-Papendieck L; Chiesa A; Mendez V; Prieto L
    J Pediatr Endocrinol Metab; 2008 Jan; 21(1):73-8. PubMed ID: 18404975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital adrenal hyperplasia newborn screening: Rio de Janeiro experience].
    Cardoso CB; Fonseca AA; Oliveira Mde F; Pereira BB; Guimarães MM
    Arq Bras Endocrinol Metabol; 2005 Feb; 49(1):112-9. PubMed ID: 16544042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing.
    Janzen N; Riepe FG; Peter M; Sander S; Steuerwald U; Korsch E; Krull F; Müller HL; Heger S; Brack C; Sander J
    Horm Res Paediatr; 2012; 77(3):195-9. PubMed ID: 22508345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.